Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.


TSX:EDT - Post by User

Comment by mercedesmanon Apr 10, 2023 4:25pm
157 Views
Post# 35387317

RE:RE:I thought…

RE:RE:I thought…

Hmmmmm

when you have achieved a 30 year career studying Sepsis ( other than buying Spectral shares) and decide to leave your professorship position at a major US University, and have run several Trials on one of the most complex human conditions to try to resolve with a RCT,  and are considered a Key Opinion Leader on the topic of Sepsis and blood perfusion world-wide ... THEN  I will consider listening to you ...over the expert. 


Until then you simply come across like a whiny child in the back seat, incapable of listening to reason when you find out from your father that the Chucky Cheese has suddenly closed due to a power outage, and you'll have to come back tomorrow. 


While an unfortunate series of events has befallen the Tigris portion of the Trial, I believe that the BoD got the memo from serious ( and large) non-insider shareholders and that Mgt are making, and will be making, a sincere effort to improve things going forward ... towards an inevitable ( albeit somewhat delayed) endgame. 

We demanded a thorough explanation, and I feel that we got one, including a discussion of new strategies being undertaken that will change the status quo ( pace of enrollment) 


MM 

<< Previous
Bullboard Posts
Next >>